FOCL logo

EDAP TMS SA -ADR

FOCLNASDAQ
πŸ† #3727 by market capUS Equity
β€”β€”
Quote unavailable
πŸ””
Track FOCL
Get earnings, price moves & breaking news on Telegram
Track
24hβ€”
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$133M
Small Cap
πŸ“ˆRevenue Growth (YoY)
126.0%
High Growth
πŸ“ŠGross Margin
47.6%
Healthy
πŸ’΅FCF Margin
10.3%
Healthy
βš–οΈP/S Ratio
2.0x
Cheap
Otter Score
β€”
Insufficient data
No chart data available for FOCL.

Trading Snapshot

Day Range
β€”
52-Week Range
$2.80 – $6.40
Volume (shares)
β€”
Avg Volume (shares)
β€”
Shares Outstanding
47.2M
Next Earnings
β€”

Fundamentals Snapshot

Annual Revenue
$71M
Last Q Revenue
$10M
P/E Ratio
β€”
P/S Ratio
2.0x
EPS (TTM)
$-1.04
Dividend Yield
β€”
Dilution (1yr)
+0.2%
FOCL logo

EDAP TMS SA -ADR

FOCL
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$71Mβ–² +2.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
42.5%β–² +2.7% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$25Mβ–² +9.8% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$21Mβ–² +32.8% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
37.4Mβ–² +0.2% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$7Mβ–Ό βˆ’$24M YoY
StockOtter Β· stockotter.space

About EDAP TMS SA -ADR

EDAP TMS S.A. operates as a holding company, with its subsidiary primarily focused on the innovation, manufacturing, and distribution of advanced, minimally invasive medical devices engineered to address urological conditions. The company's activities are organized into two principal divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU segment is dedicated to the creation, production, and commercialization of devices that employ HIFU technology for the precise, non-surgical elimination of certain localized tumors. In contrast, the UDS division concentrates on the entire lifecycleβ€”from development and marketing to manufacturing and servicingβ€”of medical instruments used for the minimally invasive diagnosis and treatment of various urological disorders, particularly urinary stones and other related clinical indications. This enterprise was founded on December 3, 1979, and its corporate headquarters are located in Vaulx-en-Velin, France.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.